Stop wasting time with stagnant workouts and unlock the proven biological trigger that forces your muscles to grow stronger, ...

Understanding human gene function in living organisms has long been hampered by fundamental differences between species.

The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the companies’ respective drug applications. Sanofi revealed Dec. 24 that the ...

Multiple sclerosis (MS) is a disorder that prompts the body's immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic nerve and spinal cord. This can in turn ...

Anthropic is finally letting more people use Claude in Google Chrome. The company's AI browser plugin is expanding beyond $200-per-month Max subscribers and is now available to anyone who pays for a ...

Corteva (NYSE: CTVA), a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, today announced a ...

The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the brains of people with progressive forms of multiple sclerosis, according to new ...

PERSEUS phase 3 study in primary progressive multiple sclerosis did not meet its primary endpoint in delaying time to onset of 6-month composite confirmed disability progression compared to placebo ...

The over-the-counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the brains of people with progressive forms of multiple sclerosis, according to new ...

GREEN BAY (WLUK) -- With a Green Bay City Council election coming this spring, a new strategy has emerged: Six candidates have united their campaign efforts. On Wednesday, the group held a launch ...

Dallas Mavericks Point Guard Kyrie Irving has announced a multi-year partnership with Paul Quinn College, bringing new resources to the only HBCU in Dallas, according to HBCU Gameday. The college is ...

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, cutting the number of relapses compared to another treatment over nearly ...